VanEck Associates’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $683K | Buy |
13,123
+3,018
| +30% | +$157K | ﹤0.01% | 1116 |
|
|
2025
Q1 | $645K | Sell |
10,105
-1,005
| -9% | -$64.1K | ﹤0.01% | 1109 |
|
|
2024
Q4 | $531K | Sell |
11,110
-506
| -4% | -$24.2K | ﹤0.01% | 1125 |
|
|
2024
Q3 | $590K | Sell |
11,616
-6,401
| -36% | -$325K | ﹤0.01% | 1069 |
|
|
2024
Q2 | $943K | Sell |
18,017
-320
| -2% | -$16.7K | ﹤0.01% | 999 |
|
|
2024
Q1 | $746K | Sell |
18,337
-25
| -0.1% | -$1.02K | ﹤0.01% | 1015 |
|
|
2023
Q4 | $679K | Sell |
18,362
-3,115
| -15% | -$115K | ﹤0.01% | 1011 |
|
|
2023
Q3 | $820K | Buy |
21,477
+654
| +3% | +$25K | ﹤0.01% | 938 |
|
|
2023
Q2 | $751K | Sell |
20,823
-2,160
| -9% | -$77.9K | ﹤0.01% | 932 |
|
|
2023
Q1 | $878K | Sell |
22,983
-1,194
| -5% | -$45.6K | ﹤0.01% | 859 |
|
|
2022
Q4 | $1.38M | Sell |
24,177
-691
| -3% | -$39.3K | ﹤0.01% | 740 |
|
|
2022
Q3 | $983K | Sell |
24,868
-6,124
| -20% | -$242K | ﹤0.01% | 776 |
|
|
2022
Q2 | $1.36M | Sell |
30,992
-3,449
| -10% | -$152K | ﹤0.01% | 736 |
|
|
2022
Q1 | $1.37M | Buy |
+34,441
| New | +$1.37M | ﹤0.01% | 779 |
|
|
2017
Q1 | – | Sell |
-1,565
| Closed | -$15K | – | 893 |
|
|
2016
Q4 | $15K | Buy |
1,565
+773
| +98% | +$7.41K | ﹤0.01% | 873 |
|
|
2016
Q3 | $10K | Sell |
792
-216
| -21% | -$2.73K | ﹤0.01% | 860 |
|
|
2016
Q2 | $9K | Buy |
1,008
+97
| +11% | +$866 | ﹤0.01% | 847 |
|
|
2016
Q1 | $9K | Buy |
+911
| New | +$9K | ﹤0.01% | 812 |
|